[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350178-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-350178-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","repeatability-of-semi-quantitative-68gaga-fapi-46-petct-measurements-in-pancreatobiliary-cancers-a-test-retest-study","Repeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers - a test-retest study","","Radiolabelled fibroblast activation protein inhibitors (FAPI) are promising molecular imaging tracers for pancreatobiliary cancer diagnosis and staging. For [68Ga]Ga-FAPI-46, day-to-day variability in tracer uptake must be quantified to enable reliable treatment-response assessment. This study evaluates the repeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in patients with pathologically confirmed pancreatobiliary cancer using two scans within 7 days, without intervening treatment.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/repeatability-of-semi-quantitative-68gaga-fapi-46-petct-measurements-in-pancreatobiliary-cancers-a-test-retest-study/350178/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/repeatability-of-semi-quantitative-68gaga-fapi-46-petct-measurements-in-pancreatobiliary-cancers-a-test-retest-study/350178.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What repeatability performance was reported for semi-quantitative measurements?","Question",{"text":63,"@type":64},"Repeatability coefficients (RC) for SUVmean, SUVpeak and SUVmax were 23.7%, 23.9% and 29.8% respectively. Blood-pool adjusted TBRmean, TBRpeak and TBRmax RCs were 21.6%, 20.8% and 28.0%, and all intraclass correlation coefficients (ICCs) were above 0.98.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},350178,1790611948,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,106,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":104,"slug":105},30,"research-report",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},9,"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","European Journal of Nuclear Medicine and Molecular Imaging (2026) 53:3827–3837  \n[https://doi.org/10.1007/s00259-025-07738-6](https://doi.org/10.1007/s00259-025-07738-6)  \nORIGINAL ARTICLE  \nRepeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers: a test-retest study  \nRutger B. Henrar1,2 · Matthijs C. F. Cysouw1,2 · Xavier Palard-Novello1,2,3 · Lothar A. Schwarte1,2 · Pieter G. H. M. Raijmakers1,2 · Lioe-Fee de Geus-Oei4,5,6 · Alexander L. Vahrmeijer4 · Geert Kazemier1,2 · Albert D. Windhorst1,2 · Ronald Boellaard1,2 · Maqsood Yaqub1,2 · Daniela E. Oprea-Lager1,2,7 ·  \nRutger-Jan Swijnenburg1,2,8  \nReceived: 12 September 2025 / Accepted: 22 December 2025 / Published online: 16 January 2026 © The Author(s) 2026  \nAbstract  \nPurpose Radiolabelled fibroblast activation protein inhibitors (FAPI) are promising molecular imaging tracers for the diagnosis and staging of pancreatobiliary cancer. To enable treatment response assessment with [68Ga]Ga-FAPI-46, the day-today variability of its uptake must be defined. This study aimed to determine the repeatability of semi-quantitative [68Ga] Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers.  \nMethods Patients with pathologically confirmed pancreatobiliary cancer (pancreatic ductal adenocarcinoma (PDAC) or cholangiocarcinoma (CCA)) were included. Patients underwent two [68Ga]Ga-FAPI-46 PET/CT scans, within 7 days, without any treatment before or between scans. Static long axial field-of-view (LAFOV) PET/CT scans were performed 60 min post-injection of [68Ga]Ga-FAPI-46 (EARL2-compliant reconstruction) . Suspected malignant lesions were semi-automatically delineated (local background-adjusted 50% isocontour of the peak standardised uptake value (SUV)) and semi-quantitative measurements were extracted (SUVmean, SUVpeak and SUVmax). Tumour-to-background ratios (TBR) were also calculated. Repeatability was assessed using the repeatability coefficient (RC) and the intraclass correlation coefficient (ICC) . Results Twelve patients were included (seven PDAC, three perihilar CCA and two intrahepatic CCA) . The median injected dose was 216 MBq (interquartile range (IQR) 167–266 MBq) and the median uptake time was 60 min (range 60–68). In total, 70 FAPI-positive lesions were delineated. The RCs of SUVmean, SUVpeak and SUVmax were 23.7%, 23.9% and 29.8%, respectively. For the blood pool adjusted TBRmean, TBRpeak and TBRmax, the RC’s were 21.6%, 20.8% and 28.0%, respectively. All ICCs were above 0.98.  \nConclusion Semi-quantitative measurements of [68Ga]Ga-FAPI-46 PET/CT have an excellent repeatability and can potentially be used in future studies to assess treatment response in pancreatobiliary cancers.  \nKeywords [68Ga]Ga-FAPI-46 · LAFOV PET/CT · Test-retest · Repeatability · Pancreatobiliary cancer  \n\n| Daniela E. Oprea-Lager and Rutger-Jan Swijnenburg contributed equally to this publication. |\n| --- |\n| Trials registry: EudraCT, EudraCT 2022-001867-29. Registered 02 November 2022. |\n\n􀀍  \n1  \n2  \n3  \n4  \nRutger-Jan Swijnenburg  \n[r.j.swijnenburg@amsterdamumc.nl](r.j.swijnenburg@amsterdamumc.nl)  \nAmsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands  \nCancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands  \nUniv Rennes, CLCC Eugène Marquis, INSERM, LTSIUMR 1099, Rennes, France  \nLeiden University Medical Center, Albinusdreef 2, Leiden, the Netherlands  \n5 University of Twente, Drienerlolaan 5, Enschede, The Netherlands  \n6 Delft University of Technology, Mekelweg 6, Delft, The Netherlands  \n7 Radboud University Medical Center, Nijmegen, the Netherlands  \n8 Department of Surgery, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands  \nIntroduction  \nRadiolabelled fibroblast activation protein inhibitor (FAPI) tracers are a novel group of radiopharmaceuticals targeting fibroblast activation protein (FAP) on the cell surface of act","cbCaiv9qDQ7arVBa","https://ap.wps.com/l/cbCaiv9qDQ7arVBa","pdf",1377956,11,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What repeatability performance was reported for semi-quantitative measurements?\",\"answer\":\"Repeatability coefficients (RC) for SUVmean, SUVpeak and SUVmax were 23.7%, 23.9% and 29.8% respectively. Blood-pool adjusted TBRmean, TBRpeak and TBRmax RCs were 21.6%, 20.8% and 28.0%, and all intraclass correlation coefficients (ICCs) were above 0.98.\"}]","Repeatability of semi-quantitative [68Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers - a test-retest study | PDF",1790087533,28,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c76e7e4a0b2c12c3a8d786fdb8bc8210.webp",983,1305,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21cafcccc598a97143d8096d152a7542.webp",982,1304,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1bda6ec66e588568c70bf710c141754e.webp",981,1303,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e78df2c4451b2e55fddf178b79894414.webp",980,1301]